In other countries
The same active substances on other registers, the same brand first.
- AbilifyBrazil · Bristol-Myers Squibb Farmacêutica LtdaSame brand
- Abilify 1 MG/ML Solucion OralSpain · 1 mg · solución oral · Otsuka Pharmaceutical Netherlands B.V.Same brand
- Abilify 1 MG/ML Solucion OralSpain · 1 mg · solución oral · Otsuka Pharmaceutical Netherlands B.V.Same brand
- ABILIFY 1 mg/ml SOLUCION ORALSpain · 1 mg · solución oral · Otsuka Pharmaceutical Netherlands B.V.Same brand
- AbilifyEuropean Union · Otsuka Pharmaceutical Netherlands B.V.Same brand
- Abilify MaintenaEuropean Union · Otsuka Pharmaceutical Netherlands B.V.Same brand
- Abilify MyCiteEuropean Union · Otsuka Pharmaceutical Netherlands B.V.Same brand
- Abilify MaintenaCroatiaSame brand
- AbilifyCroatiaSame brand
- AbilifyItaly · Compressa orodispersibile · Otsuka Pharmaceutical Netherlands BVSame brand
- Abilify MaintenaItaly · Polvere e solvente per sospensione iniettabile a rilascio prolungato · Otsuka Pharmaceutical Netherlands BVSame brand
- Abilify 1 mg/ml, drankNetherlands · Drank · Otsuka Pharmaceutical Netherlands B.V.Same brand
- Abilify 10 mg, orodispergeerbare tablettenNetherlands · Orodispergeerbare tablet · Otsuka Pharmaceutical Netherlands B.V.Same brand
- Abilify 10 mg, tablettenNetherlands · Tablet · Otsuka Pharmaceutical Netherlands B.V.Same brand
- Abilify MaintenaNew Zealand · Inj 400 mg vialSame brand
- Abilify MaintenaNew Zealand · Inj 300 mg vialSame brand
- ABILIFY 1 mg/mlRomania · 1mg/ml · sol. orala · Otsuka Pharmaceutical Netherlands B.V.Same brand
- ABILIFY 10 mgRomania · 10mg · compr. · Otsuka Pharmaceutical Netherlands B.V.Same brand
- ABILIFY 15 mgRomania · 15mg · compr. · Otsuka Pharmaceutical Netherlands B.V.Same brand
- Abilify 10MG TabletSaudi Arabia · Bristol-Myers SquibbSame brand
- Abilify 15MG TabletSaudi Arabia · Bristol-Myers SquibbSame brand
- ABILIFY MAINTENA 400 mg Powder And Solvent For Prolonged-ReleaseSaudi Arabia · Otsuka Pharmaceutical Co., LTDSame brand
- Abilify Asimtufii Prolonged-Release Suspension for Injection in Pre-Filled Syringe 960MG/3.2MLSingapore · 960mg /3.2ml · injection, suspension, extended release · Otsuka Pharmaceuticals (Singapore) Pte. LTD.Same brand
- Abilify Oral Solution 1MG/MLSingapore · 1.0 mg/ml · solution · Otsuka Pharmaceuticals (Singapore) Pte. LTD.Same brand
- Abilify Maintena Powder and Solvent for Prolonged Release Suspension for Injection 400 MGSingapore · 400mg/vial · injection, powder, for suspension, extended release · Otsuka Pharmaceuticals (Singapore) Pte. LTD.Same brand
- ABILIFY ASIMTUFII (aripiprazole) extended-release injectable suspension 720 mgTaiwan · 注射用懸液劑 · 台灣大塚製藥股份有限公司Same brand
- Abilify AsimtufiiUnited States · 720MG/2.4ML, 960MG/3.2ML · suspension, extended release · OtsukaSame brand
- Abilify Maintena KitUnited States · 300MG, 300MG/VIAL, 400MG … · for suspension, extended release · Otsuka Pharm Co LTDSame brand
- AbilifyUnited States · 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · solution · OtsukaSame brand
- Aripiprazolo Aurobindo ItaliaItaly · Soluzione orale · Aurobindo Pharma (Italia) S.R.L.Same form
- AipriBrazil · Cosmed Industria de Cosmeticos e Medicamentos S.A.Same substance
- AquarelaBrazil · Aché Laboratórios Farmacêuticos S.ASame substance
- Aripiprazol Pliva 10 mg tableteCroatia · tableta · Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, HrvatskaSame substance
- Aripiprazole SandozNew Zealand · Tab 5 mgSame substance
- Azolar®Serbia · 15mg · tableta · PredstavniŠTvo Belupo, Lijekovi I Kozmetika D.D., Beograd (Novi Beograd)Same substance
- Azolar®Serbia · 10mg · tableta · PredstavniŠTvo Belupo, Lijekovi I Kozmetika D.D., Beograd (Novi Beograd)Same substance
- Bipodis®Serbia · 5mg · tableta · Actavis D.O.O. BeogradSame substance
- Albifine Tablets 20mg (aripiprazole)Taiwan · 錠劑 · 美迪亞生技開發股份有限公司Same substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Aripiprazole
- Strength
- 960 MG / 3.2 ML
- Dosage form
- Suspension (Extended-Release)
- Route
- Intramuscular
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 20 Mar 2025
- Registration
- DIN 02554577
- Marketing authorisation holder
- Otsuka Pharmaceutical Co LTD
- ATC code
- N05AX12
- Group
- Nervous system
- Supply
- PRESCRIPTION



